NEUROBIOLOGICAL FACTORS INVOLVED IN MIGRAINE GENESIS
Abstract
Introduction: Migraine, one of the most prevalent and debilitating neurological conditions worldwide, has been the subject of intensive investigations aimed at understanding the complex neurobiological factors that contribute to its genesis. Objective: To investigate the neurobiological mechanisms of migraine and possible therapeutic approaches. Methodology: We performed a search in renowned scientific databases, including PubMed, Scopus and Web of Science, selecting studies published between 2013 and 2023 that addressed the neurobiological factors of migraine. Results and Discussion: We identified genetic influence, with variants such as MTHFR increasing the risk of migraine. Glutamatergic neurotransmission and central sensitization play crucial roles in generating pain. Activation of the trigemino-vascular system and neurogenic inflammation are implicated in seizures. Emerging therapeutic targets, such as CGRP receptor antagonists, show efficacy in prevention. Conclusion: This review covers a comprehensive overview of neurobiological factors in migraine, highlighting the importance of understanding these mechanisms for more targeted therapies. This knowledge offers new perspectives for the effective management of this debilitating condition, improving patients' quality of life.
Author Biographies
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
Â
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
Estácio - IDOMED.
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
Uninovafapi.
Uninovafapi.
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
Instituto de Educação Superior do Vale do ParnaÃba-IESVAP.
References
ANTTILA, V.; WINSVOLD, B. S.; GORMLEY, P.; KURTH, T.; BETTELLA, F.; MCMAHON, G.; PALTA, P. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nature Genetics, v. 45, n. 8, p. 912-917, 2017.
ASHINA, M.; GOADSBY, P. J.; REUTER, U. et al. Targeting the trigeminovascular pathway in migraine. Cephalalgia, v. 40, n. 12, p. 1485-1493, 2020.
CHARLES, A. Migraine: a brain state. Current Opinion in Neurology, v. 26, n. 3, p. 235-239, 2013.
CHONG, C. D.; SCHWEDT, T. J.; DODICK, D. W. Migraine: what imaging reveals. Neuroimaging Clinics of North America, v. 29, n. 4, p. 445-460, 2019.
COPPOLA, G.; DI RENZO, A.; TINELLI, E.; DI LORENZO, C.; SCAPECCIA, M.; PARISI, V.; PASCUAL, J. The CNS–peripheral nervous system relationship to the NMDA receptor in migraine: A review. The Journal of Headache and Pain, v. 16, n. 1, p. 1-9, 2015.
EDVINSSON, L.; WARFVINGE, K. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia, v. 39, n. 3, p. 366-373, 2019.
GORMLEY, P.; ANTTILA, V.; WINSVOLD, B. S.; PALTA, P.; ESKO, T.; PERS, T. H.; TZOURIO, C. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nature Genetics, v. 48, n. 8, p. 856-866, 2016.
LEVY, D.; BURSTEIN, R.; KAINZ, V.; JAKUBOWSKI, M.; STRASSMAN, A. M. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain, v. 159, n. 3, p. 193-208, 2018.
LIPTON, R. B.; DODICK, D. W.; SILBERSTEIN, S. D. et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, v. 36, n. 10, p. 957-970, 2015.
LIPTON, R. B.; SILBERSTEIN, S. D. Episodic and chronic migraine headache: Breaking down barriers to optimal treatment and prevention. Headache: The Journal of Head and Face Pain, v. 55, n. S2, p. 103-122, 2015.
NOSEDA, R.; BURSTEIN, R. Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain, v. 154, n. Suppl 1, p. S44-S53, 2013.
NOSEDA, R.; SCHAIN, A. J.; MELO-CARRILLO, A. et al. Neural mechanism of migraine. Neuron, v. 109, n. 3, p. 406-420, 2021.
PEROUTKA, S. J. What turns on a migraine? A systematic review of migraine precipitating factors. Current Pain and Headache Reports, v. 18, n. 10, p. 454, 2014.
PIETROBON, D.; MOSKOWITZ, M. A. Pathophysiology of migraine. Annual Review of Physiology, v. 75, p. 365-391, 2013.
RUSSO, A. F.; KUNKEL, R. Calcitonin gene-related peptide (CGRP) and migraine. Handbook of Experimental Pharmacology, v. 255, p. 121-130, 2019.
RUSSO, A. F.; KUNKEL, R. Revisiting the Neurogenic Inflammation in Migraine. Neurotherapeutics, v. 16, n. 1, p. 15-24, 2019.
License
Copyright (c) 2023 RECIMA21 - Revista CientÃfica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veÃculo de divulgação, seguindo os padrões nacionais e internacionais de publicação.Â